Oncology Center, King Fahad Medical City, Riyadh, KSA, Saudi Arabia.
Pulmonary Division, King Faisal Specialist Hospital and Research Center, Riyadh, KSA, Saudi Arabia.
Crit Rev Oncol Hematol. 2020 Dec;156:103120. doi: 10.1016/j.critrevonc.2020.103120. Epub 2020 Oct 10.
Treatment of patients with lung cancer during the current COVID-19 pandemic is challenging. Lung cancer is a heterogenous disease with a wide variety of therapeutic options. Oncologists have to determine the risks and benefits of modifying the treatment plans of patients especially in situation where the disease biology and treatment are complex. Health care visits carry a risk of transmission of SARS-CoV-2 and the similarities of COVID-19 symptoms and lung cancer manifestations represent a dominant problem. Efforts to modify treatment of lung cancer during the current pandemic have been adapted by many healthcare institutes to reduce exposure of lung cancer patients to SARS-CoV-2. We summarized the implications of COVID-19 pandemic on the management of lung cancer from the perspective of different specialties of thoracic oncology multidisciplinary team.
在当前 COVID-19 大流行期间，治疗肺癌患者具有挑战性。肺癌是一种异质性疾病，有多种治疗选择。肿瘤学家必须权衡修改患者治疗计划的风险和益处，特别是在疾病生物学和治疗都很复杂的情况下。就诊会有传播 SARS-CoV-2 的风险，COVID-19 症状和肺癌表现的相似性是一个主要问题。许多医疗机构都在努力调整当前大流行期间的肺癌治疗方案，以减少肺癌患者接触 SARS-CoV-2 的机会。我们从胸肿瘤多学科团队的不同专业角度总结了 COVID-19 大流行对肺癌管理的影响。
